Monday 16 November 2026 Archive edition · go to today's edition NL EN FR
← Science
ScienceHealth

WHO sets out for the first time how adults with type 1 diabetes should be treated, favouring cheaper insulin

The guidelines are meant to work in poor countries and crisis zones too, but the preference for human insulin clashes with Novo Nordisk's phase-out of insulin pens.

· latest source update zo · 3 sources · WHO, The South First, Tech Times
Illustration for this article

The World Health Organization on Saturday, World Diabetes Day, published its first guidelines on the diagnosis and treatment of type 1 diabetes in adults, the WHO announced. They are intended for all care settings, including where resources are scarce and in emergencies. According to The South First, they contain fourteen recommendations, one of them strong: several insulin injections a day, with doses adjusted to blood glucose readings.

For both mealtime and background insulin, human insulin is preferred because it is cheaper, although analogues remain an option. Pens can be considered over syringes. HbA1c, a measure of average blood sugar, should be tested at least every three months with a target of 7 percent or lower. At home this can be done with a finger prick or a sensor worn on the skin, at least three times a day. In 2025 around 9.5 million people worldwide were living with type 1 diabetes and some 500,000 new diagnoses were made. According to The South First, adults are still often wrongly diagnosed with type 2 diabetes, with a risk of dangerous complications.

Tech Times points out that the preference for human insulin coincides with Novo Nordisk phasing out human insulin pens, with the company planning to offer that insulin only in vials. Médecins Sans Frontières and the patient group T1International fear this will leave patients in poorer countries with vials while richer countries keep pens. The WHO wants everyone with type 1 diabetes to have access to affordable insulin and blood glucose self-monitoring by 2030.

Spotted a mistake in this article? Let us know.